161 related articles for article (PubMed ID: 33382132)
21. Clinical characteristics and treatment outcome of Langerhans cell histiocytosis: 22 years' experience of 154 patients at a single center.
Lee JW; Shin HY; Kang HJ; Kim H; Park JD; Park KD; Kim HS; Park SH; Wang KC; Ahn HS
Pediatr Hematol Oncol; 2014 Apr; 31(3):293-302. PubMed ID: 24397251
[TBL] [Abstract][Full Text] [Related]
22. Endocrine features of Langerhans cell histiocytosis in paediatric patients: A 30-year review.
Alexander A; Zacharin M
J Paediatr Child Health; 2024 Jan; 60(1):24-27. PubMed ID: 38031464
[TBL] [Abstract][Full Text] [Related]
23. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
24. Langerhans cell histiocytosis: differences and similarities in long-term outcome of paediatric and adult patients at a single institutional centre.
Maia RC; de Rezende LM; Robaina M; Apa A; Klumb CE
Hematology; 2015 Mar; 20(2):83-92. PubMed ID: 24875166
[TBL] [Abstract][Full Text] [Related]
25. BRAF V600E mutation in childhood Langerhans cell histiocytosis correlates with multisystem disease and poor survival.
Bhatia P; Singh M; Sharma M; Sharma A; Kakkar N; Radhika S; Trehan A; Bansal D
Blood Cells Mol Dis; 2020 May; 82():102356. PubMed ID: 32171112
[TBL] [Abstract][Full Text] [Related]
26. Craniospinal Langerhans cell histiocytosis in children: 30 years' experience at a single institution.
Davidson L; McComb JG; Bowen I; Krieger MD
J Neurosurg Pediatr; 2008 Mar; 1(3):187-95. PubMed ID: 18352762
[TBL] [Abstract][Full Text] [Related]
27. Management and Outcome of Patients With Langerhans Cell Histiocytosis and Single-Bone CNS-Risk Lesions: A Multi-Institutional Retrospective Study.
Chellapandian D; Shaikh F; van den Bos C; Somers GR; Astigarraga I; Jubran R; Degar B; Carret AS; Mandel K; Belletrutti M; Dix D; Visser J; Abuhadra N; Chang T; Rollins B; Whitlock J; Weitzman S; Abla O
Pediatr Blood Cancer; 2015 Dec; 62(12):2162-6. PubMed ID: 26179251
[TBL] [Abstract][Full Text] [Related]
28. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco.
Willis B; Ablin A; Weinberg V; Zoger S; Wara WM; Matthay KK
J Clin Oncol; 1996 Jul; 14(7):2073-82. PubMed ID: 8683239
[TBL] [Abstract][Full Text] [Related]
29. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Clinical and Imaging Findings.
Lakatos K; Sterlich K; Pötschger U; Thiem E; Hutter C; Prosch H; Minkov M
J Pediatr; 2021 Mar; 230():174-181.e1. PubMed ID: 33157073
[TBL] [Abstract][Full Text] [Related]
30. Childhood Langerhans cell histiocytosis: a disease with many faces.
Leung AKC; Lam JM; Leong KF
World J Pediatr; 2019 Dec; 15(6):536-545. PubMed ID: 31456157
[TBL] [Abstract][Full Text] [Related]
31. Clinical features, genomic profiling, and outcomes of adult patients with unifocal Langerhans cell histiocytosis.
Lang M; Cai HC; Lin H; Chang L; Dai JW; Chen J; Duan MH; Zhou DB; Goyal G; Cao XX
Orphanet J Rare Dis; 2023 Nov; 18(1):372. PubMed ID: 38037140
[TBL] [Abstract][Full Text] [Related]
32. Langerhans cell histiocytosis: 23 years' paediatric experience highlights severe long-term sequelae.
Martin A; Macmillan S; Murphy D; Carachi R
Scott Med J; 2014 Aug; 59(3):149-57. PubMed ID: 24996784
[TBL] [Abstract][Full Text] [Related]
33. Langerhans cell histiocytosis in adults: a retrospective, single-center case series.
Chiaravalli S; Ferrari A; Bergamaschi L; Puma N; Gattuso G; Sironi G; Nigro O; Livellara V; Schiavello E; Biassoni V; Podda M; Meazza C; Spreafico F; Casanova M; Terenziani M; Luksch R; Massimino M
Ann Hematol; 2022 Feb; 101(2):265-272. PubMed ID: 34635964
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre.
Bernstrand C; Sandstedt B; Ahström L; Henter JI
Acta Paediatr; 2005 Aug; 94(8):1073-84. PubMed ID: 16188852
[TBL] [Abstract][Full Text] [Related]
35. Exploration of treatment in childhood Langerhans cell histiocytosis based on inflammatory and malignant symptoms: a pilot study.
Lin HL; Zheng QQ; Huang RL; Hu R; Liu XD; Wang JY
Orphanet J Rare Dis; 2024 Apr; 19(1):174. PubMed ID: 38654381
[TBL] [Abstract][Full Text] [Related]
36. Langerhans' cell histiocytosis of the temporal bone in children.
Saliba I; Sidani K; El Fata F; Arcand P; Quintal MC; Abela A
Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):775-86. PubMed ID: 18355926
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood.
Odame I; Li P; Lau L; Doda W; Noseworthy M; Babyn P; Weitzman S
Pediatr Blood Cancer; 2006 Dec; 47(7):889-93. PubMed ID: 16276522
[TBL] [Abstract][Full Text] [Related]
38. Langerhans cell histiocytosis: retrospective evaluation of 123 patients at a single institution.
Braier J; Chantada G; Rosso D; Bernaldez P; Amaral D; Latella A; Balancini B; Masautis A; Goldberg J
Pediatr Hematol Oncol; 1999; 16(5):377-85. PubMed ID: 10505313
[TBL] [Abstract][Full Text] [Related]
39. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study.
Tazi A; Lorillon G; Haroche J; Neel A; Dominique S; Aouba A; Bouaziz JD; de Margerie-Melon C; Bugnet E; Cottin V; Comont T; Lavigne C; Kahn JE; Donadieu J; Chevret S
Orphanet J Rare Dis; 2017 May; 12(1):95. PubMed ID: 28532436
[TBL] [Abstract][Full Text] [Related]
40. [Langerhans cell histiocytosis in adult patients--a disease with many faces. Experience of a centre and an overview of the disease symptoms].
Adam Z; Pour L; Krejcí M; Neubauer J; Vanícek J; Vasků V; Hájek R
Vnitr Lek; 2008 Nov; 54(11):1063-80. PubMed ID: 19069680
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
